What are Analysts report about Vanda Pharmaceuticals Inc.(NASDAQ:VNDA): Medpace Holdings, Inc.(NASDAQ:MEDP)

0
2

Vanda Pharmaceuticals Inc. (VNDA) will report its next earnings on Jul 31 AMC. The company reported the earnings of $-0.01/Share in the last quarter where the estimated EPS by analysts was $0.06/share. The difference between the expected and actual EPS was $-0.07/share, which represents an Earnings surprise of -116.7%.

Many analysts are providing their Estimated Earnings analysis for Vanda Pharmaceuticals Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $-0.07/share and a High Estimate of $0.03/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Vanda Pharmaceuticals Inc. as 53.89 Million. According to these analysts, the Low Revenue Estimate for Vanda Pharmaceuticals Inc. is 52.23 Million and the High Revenue Estimate is 56.5 Million. The company had Year Ago Sales of 47.35 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for VNDA to be -121.4%. They are projecting Next Quarter growth of -115%. For the next 5 years, Vanda Pharmaceuticals Inc. is expecting Growth of 1238.9% per annum, whereas in the past 5 years the growth was -92.11% per annum.

Some buy side analysts are also providing their Analysis on Vanda Pharmaceuticals Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Vanda Pharmaceuticals Inc. might touch $52 high while the Average Price Target and Low price Target is $29.33 and $18 respectively.

Vanda Pharmaceuticals Inc. closed its last trading session at $13.96 with the loss of -3.8%. The Market Capitalization of the company stands at 727.91 Million. The Company has 52-week high of $33.44 and 52-week low of $13.00. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -5.22% where SMA50 and SMA200 are -10.16% and -34.49% respectively. The Company Touched its 52-Week High on 12/03/18 and 52-Week Low on 07/01/19.

The Relative Volume of the company is 0.93 and Average Volume (3 months) is 742.19 million. The company’s P/E (price to earnings) ratio is 34.17 and Forward P/E ratio of 28.88.

The company shows its Return on Assets (ROA) value of 6.6%. The Return on Equity (ROE) value stands at 8.1%. While it’s Return on Investment (ROI) value is 7.8%.

While looking at the Stock’s Performance, Vanda Pharmaceuticals Inc. currently shows a Weekly Performance of -4.48%, where Monthly Performance is 0.45%, Quarterly performance is -24.97%, 6 Months performance is -52.71% and yearly performance percentage is -30.95%. Year to Date performance value (YTD perf) value is -48.6%. The Stock currently has a Weekly Volatility of 3.23% and Monthly Volatility of 4.29%.

Medpace Holdings, Inc. (MEDP) will report its next earnings on Jul 29 AMC. The company reported the earnings of $0.64/Share in the last quarter where the estimated EPS by analysts was $0.6/share. The difference between the expected and actual EPS was $0.04/share, which represents an Earnings surprise of 6.7%.

Many analysts are providing their Estimated Earnings analysis for Medpace Holdings, Inc. and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $0.63/share. These analysts have also projected a Low Estimate of $0.58/share and a High Estimate of $0.66/share.

In case of Revenue Estimates, 6 analysts have provided their consensus Average Revenue Estimates for Medpace Holdings, Inc. as 201.17 Million. According to these analysts, the Low Revenue Estimate for Medpace Holdings, Inc. is 192.14 Million and the High Revenue Estimate is 205.07 Million. The company had Year Ago Sales of 170.14 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for MEDP to be 3.3%. They are projecting Next Quarter growth of -1.49%. For the next 5 years, Medpace Holdings, Inc. is expecting Growth of 13.48% per annum, whereas in the past 5 years the growth was 1.93% per annum.

Some buy side analysts are also providing their Analysis on Medpace Holdings, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Medpace Holdings, Inc. might touch $65 high while the Average Price Target and Low price Target is $61 and $55 respectively.

Medpace Holdings, Inc. closed its last trading session at $62.57 with the loss of -0.02%. The Market Capitalization of the company stands at 2.2 Billion. The Company has 52-week high of $71.66 and 52-week low of $43.78. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 1.56% where SMA50 and SMA200 are 7.51% and 8.5% respectively. The Company Touched its 52-Week High on 02/25/19 and 52-Week Low on 07/12/18.

The Relative Volume of the company is 0.46 and Average Volume (3 months) is 377.84 million. The company’s P/E (price to earnings) ratio is 29.98 and Forward P/E ratio of 20.97.

The company shows its Return on Assets (ROA) value of 8%. The Return on Equity (ROE) value stands at 13.4%. While it’s Return on Investment (ROI) value is 11.6%.

While looking at the Stock’s Performance, Medpace Holdings, Inc. currently shows a Weekly Performance of -3.43%, where Monthly Performance is 12.82%, Quarterly performance is 4.28%, 6 Months performance is 7.03% and yearly performance percentage is 41.28%. Year to Date performance value (YTD perf) value is 18.19%. The Stock currently has a Weekly Volatility of 1.94% and Monthly Volatility of 2.70%.

SHARE